InvestorsHub Logo
Followers 87
Posts 6772
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Wednesday, 11/01/2023 1:07:59 PM

Wednesday, November 01, 2023 1:07:59 PM

Post# of 43157
"Novavax's Updated COVID-19 Vaccine Now Approved in the EU
October 31, 2023...

"Today's approval of the only updated protein-based non-mRNA COVID-19 vaccine in the EU is an important milestone as the need for vaccination continues," said John C. Jacobs, President and Chief Executive Officer, Novavax. "Novavax is working closely with national authorities to have our updated vaccine delivered and available in Europe in the coming weeks."

Novavax is working closely with EU member states that have requested doses through the advance purchase agreement to confirm timing of dose delivery on a country-by-country basis...

When added to vaccines, Novavax's patented saponin-based Matrix-M adjuvant enhances the immune system response, making it broader and more durable...

Novavax is currently evaluating vaccines for COVID-19, influenza and COVID-19 and influenza combined."

https://ir.novavax.com/press-releases/2023-10-31-Novavaxs-Updated-COVID-19-Vaccine-Now-Approved-in-the-EU

I'm interested to see if this approval leads to an announcement regarding an opportunity for lenz.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.